F5 (FFIV) director Budnik granted 987 RSUs and converts 934 into shares

Rhea-AI Filing Summary

F5, Inc. director Marianne Budnik reported equity compensation activity. She received a grant of 987 Restricted Stock Units (RSUs) on Common Stock, each representing a right to one share when vested. These RSUs will fully vest on the first business day before the fiscal 2026 annual shareholder meeting if she continues serving as a director.

On a separate date, she exercised 934 RSUs into 934 shares of Common Stock at a price of $0.00 per share, reflecting the conversion of previously granted RSUs rather than an open-market purchase. After these transactions, she directly holds 2,141 shares of Common Stock. The filing shows only acquisitions and no share sales, indicating routine director compensation and vesting.

Insights

Equity compensation analyst

Routine director equity awards and RSU vesting with no share sales.

Director Marianne Budnik received 987 new RSUs in F5, Inc., plus converted 934 previously granted RSUs into Common Stock at $0.00 per share. These are standard compensation-related transactions rather than market purchases or sales.

The new RSUs vest in full on the first business day before the fiscal 2026 annual shareholder meeting, conditional on her continued board service. Because there are no open-market sales or large net position changes, the activity appears routine and does not materially alter the investment thesis based on this filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budnik Marianne

(Last) (First) (Middle)

C/O F5, INC.

801 5TH AVENUE

(Street)

SEATTLE WA 98104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
F5, INC. [ FFIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		M		934	A	$0	2,141	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(1)	$0	03/11/2026		M			934	(2)	(3)	Common Stock	934	$0	0	D
Restricted Stock Unit(1)	$0	03/12/2026		A		987		(4)	(3)	Common Stock	987	$0	987	D

Explanation of Responses:

1. Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date.

2. Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2025 (to be held in 2026) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

3. If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

4. Restricted Stock Units will fully vest on the first business day prior to the date of the annual shareholder meeting for fiscal 2026 (to be held in 2027) if the reporting person continues to serve as a director on the vest date, and the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

Remarks:

	/s/ Angelique M. Okeke by Power of Attorney	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did F5 (FFIV) director Marianne Budnik receive?

Director Marianne Budnik received a grant of 987 Restricted Stock Units (RSUs), each representing a right to one share of F5, Inc. Common Stock upon vesting, as part of her director compensation program.

Did Marianne Budnik buy or sell F5 (FFIV) stock in the open market?

The filing shows no open-market buys or sells. Activity consists of a 987 RSU grant and the exercise of 934 RSUs into Common Stock at $0.00 per share, reflecting vesting of prior awards rather than discretionary trading.

When do Marianne Budnik’s new F5 (FFIV) RSUs vest?

The 987 Restricted Stock Units will fully vest on the first business day before the fiscal 2026 annual shareholder meeting, provided she continues to serve as a director through that vesting date.

How many F5 (FFIV) shares does Marianne Budnik hold after these transactions?

After exercising 934 RSUs into Common Stock, Marianne Budnik directly holds 2,141 shares of F5, Inc. Common Stock, according to the reported post-transaction ownership in the Form 4.

What is the significance of the $0.00 exercise price in Marianne Budnik’s F5 filing?

The $0.00 exercise price indicates the conversion of Restricted Stock Units into Common Stock without cash payment, which is typical for RSUs. This differs from stock options, which usually require paying a strike price to exercise.

Are Marianne Budnik’s F5 (FFIV) RSU awards contingent on continued service?

Yes. The RSU footnotes state that shares will be issued only if she continues to serve as a director or provide services through the vest date, making vesting contingent on ongoing service to the company.